Author:
De Luca Nicola,Savonitto Stefano,Ricciardelli Bruno,Marchegiano Raffaele,Lamenza Fausto,Lembo Giuseppe,Trimarco Bruno
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine
Reference25 articles.
1. Kaiser G, Ackermann R, Brechbüler S, Dieterle W. Pharmacokinetics of the angiotensin converting enzyme inhibitor benazepril HCL (CGS 14824) in healthy volunteers after single and repeated administration.Biopharm Drug Dispos 1989;10:365?376.
2. Schaller MD, Nussberger J, Waeber B, et al. Haemodynamic and pharmacological effects of the converting enzyme inhibitor CGS 14824 A in normal volunteers.Eur J Clin Pharmacol 1985;28:267?272.
3. Whalen JJ. Definition of the active dose of the converting-enzyme inhibitor benazepril.Am Heart J 1989;117:728?734.
4. Weinberger MH, Black HR, Lasseter KC, et al. Diurnal blood pressure in patients with mild-to-moderate hypertension treated with once-daily benazepril hydrochloride.Clin Pharmacol Ther 1990;47:608?617.
5. Nussberger J. Resetting of the renin-angiotensin system after converting enzyme inhibition with benazepril. In: Brunner HR, Salvetti A, Sever PS, eds.Benazepril: profile of a new ACE inhibitor. London: Royal Society of Medicine Services Limited, 1990:15.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献